• 1
    Ashley D, McCaw-Binns A, Foster-Williams K. The perinatal morbidity and mortality survey in Jamaica. Paediatr Perinat Epidemiol 1988; 2: 138147.
  • 2
    Louisy C, Rotchell Y. Maternal mortality in Barbados 1970-1989 [abstract]. West Ind Med J 1990; 39: Suppl 1:16.
  • 3
    Presad P, Goopesingh T, Ali J. Hypertensive disease in pregnant women delivering before 34 weeks gestation in Trinidad [abstract]. West Ind Med J 1990; 39 Suppl 1:14.
  • 4
    Matadial L, Grell GAC, Walker G, Forrester T. Hypertensive Disease ofPregnancy. West Ind Med J 1985; 34: 225233.
  • 5
    Ibison JM, Swerdlow AJ, Head JA, Marmot M. Maternal mortality in England and Wales 1970-1985: an analysis by country of birth. Br J Obstet Gynaecol 1996; 103: 973980.
  • 6
    Chief Medical Officer of Barbados. Annual Report 1991-1992. Bridgetown , Barbados : Ministry of Health, 1995.
  • 7
    Forrester TE, Wilks RJ, Bennett FI et al. Foetal growth and cardiovascular risk factors in Jamaican schoolchildren. BM J 1996; 312:156160.
  • 8
    Barker D, Osmond C, Golding J, Kuh D, Wadsworth M. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BM J 1989; 298: 564567.
  • 9
    Freeman V, Fraser H, Forrester T et al. A comparative study of hypertension prevalence, awareness, treatment and control rates in St. Lucia, Jamaica and Barbados. J Hypertension 1996; 14: 495501.
  • 10
    Foster C, Rotimi C, Fraser H et al. Hypertension, diabetes and obesity in Barbados: findings from a population-based study. Ethnicity and Disease 1993; 3: 404412.
  • 11
    Cruickshank JK. Natural history of blood pressure in black populations in the West Indies, West Africa and the UK. In: CruickshankJK, BeeversDG, editors. Ethnic Factors in Health and Disease. London : Buttenvorth Heineman, 1989: 268279.
  • 12
    Redman CWG. Platelets and the beginnings of pre-eclampsia. N Engl J Med 1990; 323: 478480.
  • 13
    De Swiet M, Fryers G. The use of aspirin in pregnancy. J Obstet Gynaecol 1990; 10: 467483.
  • 14
    Redman CW, Bonnar J, Beilin L. Early platelet consumption in pre eclampsia. BMJ 1978; 1: 467469.
  • 15
    Dixon HG, Robertson WB. A study of the vessels of the placental bed in hypertensive pregnancy. J Obstet Gynaecol 1958; 65: 803809.
  • 16
    ECPPA Randomized trial of low-dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women in Brazil. Br J Obstet Gynaecol 1996; 103: 3947.
  • 17
    CLASP: a randomised trial of low-dose aspirin for prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619629.
  • 18
    Italian Study Group. Low-dose aspirin in prevention and treatment of intra-uterine growth retardation and pregnancy induced hypertension. Italian study of aspirin in pregnancy. Lancet 1993; 341: 396400.
  • 19
    Sibai BM, Caritis SN, Thom E et al. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women. New Engl J Med 1993; 329: 12131218.
  • 20
    Hauth JC, Goldenberg RL, Parker CR, Philips JB, Copper RL, DuBard MB, Cutter GR. Low-dose aspirin to prevent pre-eclampsia. Arn J Obsfer Gynecol 1993; 168: 10831091.
  • 21
    Collins R. Anti-platelet agents for IUGR and pre-eclampsia. In: KeirseMJNC, RenfrewMJ, NeilsonJP, CrowtherC, editors. Pregnancy and Childbirth Module. In: The Cochrane Collaboration. The Cochrane Pregnancy and Childbirth Database; Issue 2. Oxford Update Software, 1995.
  • 22
    Clarke RL, Mayo G, Price P, Fitzgerald GA. Suppression of thromboxane A, but not of systemic prostacyclin by controlled release aspirin. N Engl J Med 1991; 325: 11371141.
  • 23
    David R, Collins JW. Differing birth weight among infants of US-born Blacks, African-born Blacks and US-born Whites. N Engl J Med 1997; 337: 12091214.
  • 24
    Dekker GA. The pharmocological prevention of pre-eclampsia [review]. Bailleres Clin Obstet Gynaecol 1995; 9: 509528.
  • 25
    Villar J, Bergsjo P. Scientific basis for the content of routine antenatal care: 1. Philosophy, recent studies, and power to eliminate or alleviate adverse maternal outcomes. Acta Obstet Gynecol Scand 1997; 76: 114.
  • 26
    Lindheimer MD. Pre-eclampsia-eclampsia 1996: preventable? Have disputes on its treatment been resolved Curr Opin Nephrol Hypertens 1996; 5: 452458.
  • 27
    Grifiths J, Rotchell YE, Cruickshank JK et al. The Barbados low- dose aspirin study in pregnancy (BLASP): a population -based trial in a developing country with excess pre-eclampsia and perinatal mortality [abstract]. In: Proceedings of the 41st Scientific Meeting of the Commonwealth Caribbean Meadical Research Council; 17-20 Apr 1996; Port of Spain, Trinidad. West Ind Med J 1996; 45 Suppl 2: 26.
  • 28
    Forrester T, Jones D, McCaw-Binns A et al. Low-dose aspirin in pregnancy; are there any benefits? [abstract]. In: Proceedings of the 41st Scientific Meeting of the Commonwealth Caribbean Meadical Research Council; 17-20 Apr 1996; Port of Spain, Trinidad. West Ind Med J 1996; 45 Suppl 2:26.